Clinical Chemistry and Immunodiagnostic Technologies, and Strategic Profiles of Leading Suppliers

June 2016 | 145 pages | ID: C77C1804879EN
Venture Planning Group

Abstracts

This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics, molecular diagnostics and others.

Contents

Current and Emerging Technologies
Monoclonal and Polyclonal Antibodies
Immunoassays
    a. Technological Principle
    d. Chemiluminescence
    c. Enzyme Immunoassays (EIA)
      Overview
      ELISA      EMIT
      Electrochemical
    d. Radioimmunoassays (RIA)
    e. Immunoprecipitation
    f. Affinity Chromatography
IT and Automation
Dry Chemistry
Biosensors
Robotics
Molecular Diagnostics
    a. Detection Technologies
  1. RADIOACTIVE METHODS
  2. NONISOTOPIC METHODS
    b. Instrumentation Review
Abbott LCX
BeckmanCoulter/Biomek FX
Becton Dickinson
BioRad Gene Scope
GenProbe
Roche Cobas Amplicor
Tecan LS Series
    c. Biochips Genosensor, Microarrays, LabsontheChips
Chemometrics

COMPETITIVE PROFILES

Abbott Laboratories
AdnaGen/Alere
Agilent Technologies
Bayer Healthcare
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
BioRad
DiaSorin
Eiken
Fujirebio
Grifols
Instrumentation Laboratory
Kyowa Medex
Matritech
OrthoClinical Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE